Characterizing the efficacy of cancer therapeutics in patient-derived xenograft models of metastatic breast cancer.
Tia H TurnerMohammad A AlzubiSahib S SohalAmy L OlexMikhail G DozmorovJ Chuck HarrellPublished in: Breast cancer research and treatment (2018)
This study highlights the utility of PDX models for studying the efficacy of therapeutics in reducing metastatic burden in specific organs. The differential treatment responses between two PDX models of the same intrinsic subtype, in both the primary and metastatic setting, recapitulates the challenges faced in treating cancer patients and highlights the need for combination therapies and predictive biomarkers.